2007
DOI: 10.1016/j.ijom.2006.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Serum levels of insulin-like growth factors (IGFs) and their binding proteins (IGFBPs), -1, -2, -3, in oral cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
27
2

Year Published

2008
2008
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(40 citation statements)
references
References 16 publications
(16 reference statements)
3
27
2
Order By: Relevance
“…On the other hand, down-regulation of IGFBP-3 has been found in patients with tongue carcinoma and significantly associated with shorter disease-specific survival [70]. In addition, patients with head and neck cancer have been shown to have increased plasma levels of IGFBP-1 and IGFBP-2 in contrast to the levels of IGF-1 and IGFBP-3, which were found to be low [71]. However, no significant association was demonstrated between these findings and the tumor size or nodal status.…”
Section: Other Factors Implicated In Lymphangiogenesismentioning
confidence: 99%
“…On the other hand, down-regulation of IGFBP-3 has been found in patients with tongue carcinoma and significantly associated with shorter disease-specific survival [70]. In addition, patients with head and neck cancer have been shown to have increased plasma levels of IGFBP-1 and IGFBP-2 in contrast to the levels of IGF-1 and IGFBP-3, which were found to be low [71]. However, no significant association was demonstrated between these findings and the tumor size or nodal status.…”
Section: Other Factors Implicated In Lymphangiogenesismentioning
confidence: 99%
“…On the contrary, Brady et al showed that circulating levels of both IGF1 and IGFBP3 protein are decreased in head and neck cancer patients (Brady et al, 2007).…”
Section: Introductionmentioning
confidence: 96%
“…Only a few studies have investigated head and neck cancer and IGF-1 association (Doyle et al, 2012;Brady et al, 2007) It has been reported that patients with head and neck cancer that developed second primary tumors have high levels of IGF-1 and low levels of IGFBP-3, so these markers (IGF1/IGFBP-3) represent positive risk factors (Wu et al, 2004). On the contrary, Brady et al showed that circulating levels of both IGF1 and IGFBP3 protein are decreased in head and neck cancer patients (Brady et al, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…However, serum levels of IGFBP-1 and IGFBP-2 were elevated. 41 Papadimitrakopoulou et al showed that downregulation of IGFBP-3 is a highly significant predictor of poor outcome for patients with tongue cancer. 42 Previous studies have described the expression of various proteins of the IGF system in normal oral and epithelial tumour cell lines.…”
Section: Discussionmentioning
confidence: 99%